Home / Health / FDA Approves Home Brain Stimulator for Depression
FDA Approves Home Brain Stimulator for Depression
20 Jan
Summary
- FDA-approved FL-100 device offers at-home depression treatment.
- The device uses gentle electrical current to stimulate brain activity.
- Significant symptom improvement seen in 10-week clinical trial.
A groundbreaking FDA approval ushers in a new era for depression treatment, allowing adults to use a prescription brain-stimulation device at home. The FL-100, developed by Flow Neuroscience, is designed for individuals aged 18 and older experiencing moderate to severe major depressive disorder. It can be prescribed as a standalone therapy or in conjunction with other treatments.
This innovative technology, known as transcranial direct current stimulation (tDCS), delivers a mild electrical current to the brain's prefrontal cortex. This region is crucial for mood regulation and stress response, and is often less active in individuals with depression. The goal is to restore healthier brain signaling over time.
A randomized controlled trial demonstrated the device's efficacy, with participants showing substantial symptom improvement within 10 weeks. Many reported noticeable changes in just three weeks, with generally mild and short-term side effects like skin irritation or headaches.
The FL-100 has seen widespread use in Europe and other regions, and its US approval is anticipated to increase access to non-drug mental health solutions. Flow Neuroscience expects the device to be available in the US in the second quarter of 2026, requiring a prescription and utilizing a companion mobile app for remote monitoring.
